Key facts
- Echo Neurotechnologies’s last known valuation is $150.0M (Jan 2025).
- It has raised $50.0M; the latest was Early Stage VC ($50.0M) in Jan 2025.
- Notable investors include Andreessen Horowitz, A&E Investments.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Echo Neurotechnologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Echo Neurotechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Echo Neurotechnologies
Developer of neuroscience products designed to improve lives. The company's products use brain-computer interfaces to restore conversational communications, enabling patients with severe disabilities to interact with others.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Website
- echo.bio/
- Ownership
- Privately Held (backing)
Echo Neurotechnologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Echo Neurotechnologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Echo Neurotechnologies in its N-PORT filings yet. We sweep new filings monthly.